1,10-phenanthroline has been researched along with Leukemia, Myeloid in 2 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, B | 1 |
Wu, KF | 1 |
Cao, ZY | 1 |
Rao, Q | 1 |
Ma, XT | 1 |
Zheng, GG | 1 |
Li, G | 1 |
Sestili, P | 1 |
Guidarelli, A | 1 |
Dachà , M | 1 |
Cantoni, O | 1 |
2 other studies available for 1,10-phenanthroline and Leukemia, Myeloid
Article | Year |
---|---|
IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression.
Topics: Antibodies, Monoclonal; Cell Movement; Extracellular Matrix; Gene Expression Regulation, Enzymologic | 2004 |
Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism.
Topics: Antioxidants; Butylated Hydroxytoluene; Cell Death; Chromans; Copper; DNA Damage; Dose-Response Rela | 1998 |